TEVA vs. IHE
Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and iShares U.S. Pharmaceuticals ETF (IHE).
IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TEVA or IHE.
Correlation
The correlation between TEVA and IHE is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
TEVA vs. IHE - Performance Comparison
Key characteristics
TEVA:
0.84
IHE:
0.75
TEVA:
1.72
IHE:
1.14
TEVA:
1.22
IHE:
1.13
TEVA:
0.45
IHE:
0.97
TEVA:
5.97
IHE:
2.04
TEVA:
6.18%
IHE:
4.68%
TEVA:
44.15%
IHE:
12.79%
TEVA:
-90.80%
IHE:
-38.20%
TEVA:
-74.53%
IHE:
-3.89%
Returns By Period
In the year-to-date period, TEVA achieves a -22.60% return, which is significantly lower than IHE's 5.69% return. Over the past 10 years, TEVA has underperformed IHE with an annualized return of -10.74%, while IHE has yielded a comparatively higher 4.31% annualized return.
TEVA
-22.60%
-19.68%
0.89%
37.80%
7.11%
-10.74%
IHE
5.69%
5.42%
4.50%
8.19%
6.61%
4.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TEVA vs. IHE — Risk-Adjusted Performance Rank
TEVA
IHE
TEVA vs. IHE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TEVA vs. IHE - Dividend Comparison
TEVA has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.64%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% |
IHE iShares U.S. Pharmaceuticals ETF | 1.64% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% |
Drawdowns
TEVA vs. IHE - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.80%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for TEVA and IHE. For additional features, visit the drawdowns tool.
Volatility
TEVA vs. IHE - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 17.02% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.18%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.